biotech · Bacterial Infection
4Ammonium Biotech
Centauri Biotech SL
Centauri Biotech SL is a biotech organization headquartered in EU. Primary therapeutic focus areas include Bacterial Infection. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to thi
EU HQ
3 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Employees
- 3
- Programs
- 1
- Drugs
- 2
- Patents
- 0
CTX-187-101
Phase 1 · other · Bacterial Infection
CTX-187-101 for Bacterial Infection is a Phase 1 program (other) at Centauri Biotech SL with 1 ClinicalTrials.gov record(s).
Internal code CTX-187-101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Centauri Biotech SL
- Phase
- Phase 1
- Modality
- other
- Indication
- Bacterial Infection
- Status
- active
- Trials
- 1